Fundraising FoxRain Therapeutics
Fremont, US · Founded 2017 · Delaware corporation · 8 known investors
Find your way into Rain Therapeutics
Sign up to see every warm intro you have to Rain Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rain Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Rain Therapeutics was founded in 2017 by Avanish Vellanki.
Investors · 8
Biotechnology Value FundreportedSan Francisco
How we know: funding news · biospace.com · Not right? Tell us
Janus Henderson InvestorsreportedLondon
How we know: funding news · biospace.com · Not right? Tell us
Samsara BioCapitalreportedMenlo Park
How we know: funding news · biospace.com · Not right? Tell us
Also in the syndicate · 5
Auckland UniServices Limited’s Inventors FundBoxer CapitalleadCormorant Asset ManagementLogos CapitalPerceptive Advisors
Reported raises · per SEC filings
Form D private placements$92M disclosed across 3 rounds · 2017–2020
▶$72.6MraisedSep 2020 · 18 investors · BiotechnologyRule 506(b)
▶$72.6MraisedSep 2020 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tran NguyenDirector
- Peter RadovichDirector
- Gorjan HrustanovicDirector
- Aaron DavisDirector
- Franklin BergerDirector
- Avanish VellankiExecutive Officer, Director
- Offering amount
- $72.6M
- Amount sold
- $72.6M
- Minimum investment
- $1
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$18.4MraisedMay 2018 · 8 investors · BiotechnologyRule 506(b)
▶$18.4MraisedMay 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Avanish VellankiExecutive Officer
- Offering amount
- $18.4M
- Amount sold
- $18.4M
- Minimum investment
- $50K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1MraisedDec 2017 · 24 investors · PharmaceuticalsRule 506(b)
▶$1MraisedDec 2017 · 24 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Avanish VellankiExecutive Officer
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $10K
- Proceeds to insiders
- $34K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Rain Therapeutics?
- Rain Therapeutics was founded by Avanish Vellanki in 2017.
- Who are Rain Therapeutics's investors?
- Rain Therapeutics's investors include Biotechnology Value Fund, Janus Henderson Investors, Samsara BioCapital.
- How much funding has Rain Therapeutics raised?
- Rain Therapeutics has disclosed $92M raised across 3 rounds.
- Where is Rain Therapeutics headquartered?
- Rain Therapeutics is headquartered in Fremont, US.